Outcome of Radiation Therapy in Urinary Bladder Squampus Cell Carcinoma
- Conditions
- Urinary Bladder Squamous Cell Carcinoma
- Registration Number
- NCT04815629
- Lead Sponsor
- Assiut University
- Brief Summary
Detection of distribution of clinico-pathological features of squamous cell carcinoma of urinary bladder and their relation to treatment outcome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- age 18-70 .
- histologically proved urinary bladder squamous cell carcinoma.
- non-metastatic disease.
- all patients who underwent radical treatment or bladder preserving approach.
- patient with isolated urinary bladder carcinoma (no other or previous primary).
Exclusion Criteria
- age < 18 , > 70.
- patient not documented having bladder squamous cell carcinoma by biopsy (cystoscopic or operative).
- metastatic disease.
- patient with synchronous or metachronous double primary
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease free survival baseline Disease free survival
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways in bladder squamous cell carcinoma influence radiation therapy outcomes in NCT04815629?
How does radical radiation therapy compare to cystectomy in bladder SCC survival rates and recurrence patterns?
Which biomarkers correlate with treatment response in NCT04815629 bladder SCC radiation therapy cohort?
What are the acute and chronic toxicities of radical radiation for bladder SCC in observational studies?
Are there synergistic effects of immunotherapy with radiation in bladder SCC treatment strategies?
